469.16
price up icon0.16%   0.75
after-market Handel nachbörslich: 463.00 -6.16 -1.31%
loading

Vertex Pharmaceuticals Inc Aktie (VRTX) Neueste Nachrichten

pulisher
Jul 29, 2025

Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Jul 29, 2025
pulisher
Jul 29, 2025

Volume Surge May Signal Institutional Interest in Vertex Pharmaceuticals IncorporatedStable Entry High Return Opportunities in Focus - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Vertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards? - TradingView

Jul 29, 2025
pulisher
Jul 29, 2025

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jul 29, 2025
pulisher
Jul 28, 2025

Vertex Pharmaceuticals' (VRTX) Upcoming Earnings and Strategic Momentum: A Deep Dive into Long-Term Growth Potential Amid Pipeline Advancements and Financial Resilience - AInvest

Jul 28, 2025
pulisher
Jul 28, 2025

Vertex Pharmaceuticals (VRTX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance

Jul 28, 2025
pulisher
Jul 28, 2025

How does Vertex Pharmaceuticals Incorporated generate profit in a changing economyMaximize your gains with expert trading tips - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Vertex Pharmaceuticals Incorporated stockAI Powered Entry Points That Work - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Vertex Pharmaceuticals Incorporated (VRTX) Launches JOURNAVX, First Non-Opioid Acute Pain Treatment - MSN

Jul 28, 2025
pulisher
Jul 28, 2025

The 3 Things That Matter for Vertex Pharmaceuticals Now - AOL.com

Jul 28, 2025
pulisher
Jul 28, 2025

The 3 Things That Matter for Vertex Pharmaceuticals Now - The Motley Fool

Jul 28, 2025
pulisher
Jul 28, 2025

Vertex Pharmaceuticals (VRTX): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance

Jul 28, 2025
pulisher
Jul 27, 2025

Should I hold or sell Vertex Pharmaceuticals Incorporated stock in 2025Rapid growth opportunities - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Why is Vertex Pharmaceuticals Incorporated stock attracting strong analyst attentionInvest confidently with real-time data - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 22:21:17 - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Vertex Pharmaceuticals Incorporated a growth stock or a value stockSuperior portfolio returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 26, 2025

Truist Financial Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX) - The Globe and Mail

Jul 26, 2025
pulisher
Jul 26, 2025

Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need to Know - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

Vertex Bets Big On Rare Diseases And Pain Medicine - Finimize

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Vertex Pharmaceuticals Incorporated stock priceHigh-octane financial growth - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Can Vertex Pharmaceuticals Incorporated stock recover from recent declineFree Risk Assessment Services - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

Three Indian American-led firms among TIME100 Most Influential Companies - The American Bazaar

Jul 24, 2025
pulisher
Jul 23, 2025

Vertex Pharmaceuticals Incorporated Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Vertex Pharmaceuticals (VRTX) Rises Higher Than Market: Key Facts - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

Vertex Pharmaceuticals (VRTX) Advances Cystic Fibrosis Treatment With ALYFTREK Approval in Canada - Yahoo Finance

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Vertex Pharmaceuticals Incorporated stockFree Stock Market Return Analysis - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Vertex Pharmaceuticals (VRTX) Gets a Buy from Citi - The Globe and Mail

Jul 23, 2025
pulisher
Jul 22, 2025

Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Cystic Fibrosis Pipeline Outlook 2025: Insights into Drug Development and Leading 50+ Companies - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Vertex Pharmaceuticals: Pioneering Orphan Drug Innovation in Cystic Fibrosis and Cementing Market Leadership - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Vertex Announces Marketing Authorization in Canada for ALYFTREK, a Once-Daily Next-Generation CFTR Modulator for the Treatment of Cystic Fibrosis - The Malaysian Reserve

Jul 22, 2025
pulisher
Jul 22, 2025

Is Vertex Pharmaceuticals Incorporated a good long term investmentTriple-digit wealth increases - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Vertex Pharmaceuticals (VRTX) Gets a Hold from Wells Fargo - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Vertex Pharmaceuticals' Quarterly Earnings Preview: What You Need To Know - Barchart.com

Jul 22, 2025
pulisher
Jul 22, 2025

3 Healthcare Stocks to Buy Before They Announce Game-Changing Clinical Trial Results - Yahoo Finance

Jul 22, 2025
pulisher
Jul 21, 2025

Sickle Cell Disease Market Set to Grow Substantially Through 2034, DelveInsight Projects | Sanofi, CSL Behring, ITB-Med LLC, Novo Nordisk A/S, Fortrea, Inc., Novartis, Afimmune, Pfizer, ADDMEDICA SASA - The Globe and Mail

Jul 21, 2025
pulisher
Jul 21, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 21, 2025
pulisher
Jul 18, 2025

Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today - Benzinga

Jul 18, 2025
pulisher
Jul 16, 2025

Vertex Pharmaceuticals (VRTX): Can Strong Catalysts Propel Outperformance Ahead of Earnings? - AInvest

Jul 16, 2025
$554.58
price down icon 0.64%
$339.80
price up icon 2.80%
$598.89
price up icon 0.02%
biotechnology ONC
$299.94
price down icon 1.90%
$110.05
price down icon 1.28%
Kapitalisierung:     |  Volumen (24h):